Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000077 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 4, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
15,000
Total Value
$1,056,486.02
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 1, 2026 | Sale | 3,557 | $69.40 | $246,855.80 | 608,983 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 1, 2026 | Sale | 8,149 | $70.50 | $574,504.50 | 600,834 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 1, 2026 | Sale | 3,294 | $71.38 | $235,125.72 | 597,540 | Direct | โ | View Details |